Open Access

Optimising outcomes for atrial fibrillation patients undergoing cardiac interventions

Event: EHRA 2022
Topic: Oral Anticoagulation
Session type: Satellite Symposium
Sponsored by BMS/Pfizer Alliance
Date: 4 April 2022
Time: 13:10 - 13:55

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

4 presentations in this session

What are the clinical burden and unmet needs of patients with atrial fibrillation undergoing cardiac interventions?

Speaker: Professor D. Connolly (Birmingham, GB)
Thumbnail

Expert discussion: how to balance antithrombotic benefit and risk in atrial fibrillation patients with acute coronary syndrome undergoing percutaneous coronary intervention?

Speaker: Associate Professor T. Potpara (Belgrade, RS)
Thumbnail

Expert discussion: what evidence supports anticoagulant therapy use in patients with atrial fibrillation requiring transcatheter aortic valve implantation?

Speaker: Professor D. Connolly (Birmingham, GB)
Thumbnail

Audience discussion and close.

Speaker: Professor D. Connolly (Birmingham, GB)
Thumbnail

4 speakers from this session

Professor Derek Leslie Connolly

City Hospital, Birmingham (United Kingdom of Great Britain & Northern Ireland)
12 presentations
0 follower

Associate Professor Tatjana Potpara

School of Medicine, Belgrade University, Belgrade (Serbia)
33 presentations
1 follower

Professor Derek Leslie Connolly

City Hospital, Birmingham (United Kingdom of Great Britain & Northern Ireland)
12 presentations
0 follower

Professor Derek Leslie Connolly

City Hospital, Birmingham (United Kingdom of Great Britain & Northern Ireland)
12 presentations
0 follower

This platform is supported by

logo Novo Nordisk